These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23368661)

  • 1. Liver toxicity due to olanzapine.
    Domínguez-Jiménez JL; Puente-Gutiérrez JJ; Pelado-García EM; Cuesta-Cubillas D; García-Moreno AM
    Rev Esp Enferm Dig; 2012 Dec; 104(11):617-8. PubMed ID: 23368661
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible olanzapine-induced hepatotoxicity in a young Chinese patient.
    Lui SY; Tso S; Lam M; Cheung EF
    Hong Kong Med J; 2009 Oct; 15(5):394-6. PubMed ID: 19801701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.
    Srivastava A; Borkar HA; Chandak S
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):119-21. PubMed ID: 19067992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute hepatocellular lesion after successive exposure to clozapine and olanzapine in a patient with chronic hepatitis C infection].
    Gómez Espín R; Sánchez Quiles I; Hallal H; Plaza J
    Gastroenterol Hepatol; 2010 Feb; 33(2):150-2. PubMed ID: 19914745
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment.
    Oglodek E; Szota A; Araszkiewicz A
    Aust N Z J Psychiatry; 2013 Oct; 47(10):972. PubMed ID: 23630396
    [No Abstract]   [Full Text] [Related]  

  • 6. Four cases of venous thromboembolism associated with olanzapine.
    Maly R; Masopust J; Hosak L; Urban A
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):116-8. PubMed ID: 19067990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-onset cholestatic hepatitis induced by olanzapine in a patient with schizophrenia.
    Hung CC; Wei IH; Huang CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1574-5. PubMed ID: 19766687
    [No Abstract]   [Full Text] [Related]  

  • 8. Clozapine toxicity and hepatitis.
    Brown CA; Telio S; Warnock CA; Wong AH
    J Clin Psychopharmacol; 2013 Aug; 33(4):570-1. PubMed ID: 23764687
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypotension secondary to the combination of intramuscular olanzapine and intramuscular lorazepam.
    Zacher JL; Roche-Desilets J
    J Clin Psychiatry; 2005 Dec; 66(12):1614-5. PubMed ID: 16401168
    [No Abstract]   [Full Text] [Related]  

  • 10. Massive pulmonary emboli associated with olanzapine.
    Hilli MA; MacRedmond R; Hollywood P; O'Neill S; Morgan R
    Ir Med J; 2008 Jun; 101(6):186. PubMed ID: 18700515
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypothermia under olanzapine treatment: clinical case series and review of current literature].
    Kreuzer P; Landgrebe M; Wittmann M; Hajak G; Schecklmann M; Poeppl TB; Langguth B
    Nervenarzt; 2012 May; 83(5):630-7. PubMed ID: 21626387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of antipsychotic-induced restless legs syndrome with gabapentin.
    Kumar V; Ambekar N; Singh A; Venkatasubramanian G
    Asian J Psychiatr; 2014 Jun; 9():89-90. PubMed ID: 24813045
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancreatitis and cholestatic hepatitis induced by risperidone.
    Cordeiro Q; Elkis H
    J Clin Psychopharmacol; 2001 Oct; 21(5):529-30. PubMed ID: 11593080
    [No Abstract]   [Full Text] [Related]  

  • 14. A patient treated with olanzapine developing diabetes de novo: proposal for hyperglycaemia screening.
    Duiverman ML; Cohen D; van Oven W; Nieboer P
    Neth J Med; 2007 Oct; 65(9):346-8. PubMed ID: 17954954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine-induced acute rhabdomyolysis-a case report.
    Baumgart U; Schmid R; Spiessl H
    Pharmacopsychiatry; 2005 Jan; 38(1):36-7. PubMed ID: 15706465
    [No Abstract]   [Full Text] [Related]  

  • 16. Risperidone-induced hepatotoxicity.
    Benazzi F
    Pharmacopsychiatry; 1998 Nov; 31(6):241. PubMed ID: 9930641
    [No Abstract]   [Full Text] [Related]  

  • 17. Risperidone alternative for a schizophrenic patient with olanzapine-exacerbated diabetic mellitus.
    Wu PL; Lane HY; Su KP
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):115-6. PubMed ID: 16472369
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatal agranulocytosis: the use of olanzapine in a patient with schizophrenia and myelodysplasia.
    Stip E; Langlois R; Thuot C; Mancini-Marïe A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):297-300. PubMed ID: 16978752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reappearance of tardive dystonia with olanzapine treated with clozapine.
    García-Lado I; García-Caballero A; Recimil MJ; Area R; Ozaita G; Lamas S
    Schizophr Res; 2005 Jul; 76(2-3):357-8. PubMed ID: 15949669
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful re-exposure to clozapine following uneventful rechallenge with olanzapine in a patient with neutropenia related to both agents.
    Wu SY; Liu CC; Hsieh MH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1089-90. PubMed ID: 18407390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.